Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 3
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Periodic table screening for enhanced positive contrast in MRI and <i>in vivo</i> uptake in glioblastoma

  • Herraiz, Aitor
  • Morales, M. Puerto
  • Martínez-Parra, Lydia
  • Arias-Ramos, Nuria
  • López-Larrubia, Pilar
  • Gutiérrez, Lucía
  • Mejías, Jesús
  • Díaz-Ufano, Carlos
  • Ruiz-Cabello, Jesús
  • Herranz, Fernando
The quest for nanomaterial-based imaging probes that can provide positive contrast in MRI is fueled by the necessity of developing novel diagnostic applications with potential for clinical translation that current gold standard probes cannot provide. Although interest in nanomaterials for positive contrast has increased in recent years, their study is less developed than that of traditional negative contrast probes in MRI. In our search for new magnetic materials with enhanced features as positive contrast probes for MRI, we decided to explore the chemical space to comprehensively analyze the effects of different metals on the performance of iron oxide nanomaterials already able to provide positive contrast in MRI. To this end, we synthesized 30 different iron oxide-based nanomaterials. Thorough characterization was performed, including multivariate analysis, to study the effect of different variables on their relaxometric properties. Based on these results, we identified the best combination of metals for in vivo imaging and tested them in different experiments. First, we tested its performance on magnetic resonance angiography using a concentration ten times lower than that clinically approved for Gd. Finally, we studied the capability of these nanomaterials to cross the affected blood–brain barrier in a glioblastoma model. The results showed that the selected nanomaterials provided excellent positive contrast at large magnetic field and were able to accumulate at the tumor site, highlighting the affected tissue
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

HAP-Multitag, a PET and Positive MRI Contrast Nanotracer for the Longitudinal Characterization of Vascular Calcifications in Atherosclerosis

  • Pellico, J
  • Fernandez-Barahona, I
  • Ruiz-Cabello, J
  • Gutierrez, L
  • Munoz-Hernando, M
  • Sanchez-Guisado, MJ
  • Aiestaran-Zelaia, I
  • Martinez-Parra, L
  • Rodriguez, I
  • Bentzon, J
  • Herranz, F
Vascular microcalcifications are associated with atherosclerosis plaque instability and, therefore, to increased mortality. Because of this key role, several imaging probes have been developed for their in vivo identification. Among them, [F-18]FNa is the gold standard, showing a large uptake in the whole skeleton by positron emission tomography. Here, we push the field toward the combined anatomical and functional early characterization of atherosclerosis. For this, we have developed hydroxyapatite (HAP)-multitag, a bisphosphonatefunctionalized Ga-68 core-doped magnetic nanoparticle showing high affinity toward most common calcium salts present in microcalcifications, particularly HAP. We characterized this interaction in vitro and in vivo, showing a massive uptake in the atherosclerotic lesion identified by positron emission tomography (PET) and positive contrast magnetic resonance imaging (MRI). In addition, this accumulation was found to be dependent on the calcification progression, with a maximum uptake in the microcalcification stage. These results confirmed the ability of HAP-multitag to identify vascular calcifications by PET/(T-1)MRI during the vulnerable stages of the plaque progression.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

A single-step radiolabeling strategy for PET, SPECT, and therapeutic radionuclides using nanoparticles as a universal chelator

  • Herraiz, Aitor
  • Rodríguez-San-Pedro, Andrea
  • Casquero-Veiga, Marta
  • Cossío, Unai
  • Arias-Ramos, Nuria
  • Gutiérrez, Lucía
  • Romero-Sanz, Eduardo
  • Luján-Rodríguez, Víctor Manuel
  • Cerón, Carlos
  • Oteo, Marta
  • González-Paredes, Ana
  • López-Larrubia, Pilar
  • Rosales, Rafael T. M. de
  • Cortes-Canteli, Marta
  • Morcillo, Miguel A.
  • Ruiz-Cabello, Jesús
  • Pellico, Juan
  • Herranz, Fernando
Radiopharmaceuticals that combine diagnostic and therapeutic isotopes are at the forefront of novel cancer treatments. A crucial element is the method of attaching radioisotopes to biomolecules using chelator-based techniques that are widely used clinically. Selection from available chelators is essential because this choice influences the physicochemical and biological characteristics of the final radiopharmaceutical. Numerous chelators exist because none fulfill all ideal conditions: rapid and complete binding to radiometals at low concentrations and with metallic impurities, high thermodynamic and kinetic stability in vivo, easy bioconjugation, and, key for this work, achieving these for many radiometals from the growing list of medical isotopes. We demonstrate how nanotechnology may change this. Ten nano-radiotracers were synthesized, incorporating radiometals such as 68Ga, 64Cu, 89Zr, 99mTc, 201Tl, 111In, 67Ga, 177Lu, 223Ra, and 225Ac into the nanoparticle core. The versatility of the platform was demonstrated through proof-of-concept experiments, including passive targeting in glioblastoma, active targeting of thrombosis, intratumoral radiotherapy in glioblastoma, and renal clearance optimization. This nanotracer addresses traditional challenges in radiopharmaceutical development, offering a single platform with consistent physicochemical and biological properties regardless of the radioisotope used for robust diagnostic and therapeutic applications.